Just wanted to clarify the process re the patent (and or licensing etc) sale offering in the European theater.
Since bashers on message boards state or imply all is lost before the real world PROCESS even has time to play out.
Potential buyers will have patent agents who "crawl" through either new patent applications or newly issued patents, or in the case of the European Union, the country publication of such. Each potential buyer will determine its own timing for crawling through these records (e.g., the patent itself or the publication).
Prior to the internet (yes, for young peoples benefit the world existed before the internet and before computers,calculators, phones and cars etc) you had to physically go to individual offices to pour through the stacks. I personally did this while I was young on a board and then as President (because its almost impossible to find people who know how to or are willing to do things or who can think- a commodity not valued outside of think tanks); long before Al Gore invented the internet,starting about the time dos PC's (brazenly called PC's -just glorified calculators) were invented long before the internet- but in a non-biotech field.
"Since our first announcement of the offer of 12 July we have registered the patent in fourteen EU Patent Agreement signatory countries. That registration was completed by 7 September. At that time the official status of the FlatPack patent in Europe was recognized in those fourteen countries."
Led by the misinformation of bashers some assume nothing is being done between updates. Think about that. Without considerable interim work these substantial updates could not be issued. As president of a corporation I did an incredible amount of work moving things forward in between board meetings,which I led.
So from July 12 to September 7 "we have registered the patent in fourteen EU Patent Agreement signatory countries".
NNLX previous patent attorney took some steps re patents in European countries-you would have to read that previous info to see what.
Big pharma's crawlers will in most cases no doubt crawl at this stage rather than waiting for publication. Lesser pharma and hospital supply organizations more likely would wait until publication.
"Since 7 September, two of those countries, Sweden and Croatia, out of the fourteen countries in which the patent has been registered, have published that information in either their own national patent bulletins or the EU Patent bulletin. This publication step is generally required in order for a formal acceptance of the patent validity by interested parties. NanoLogix has no control over the timing of individual Country publication and hopes the remainder of the bulletin notifications could be completed by the end of the current quarter, fully realizing each country involved possesses its own separate bureaucracy and timetables. That stated, we are pleased to have had interest in the technology from companies in three European and adjacent countries."
So from Sept 7 to 11-27-17 Sweden and Croatia published and the contextual inference is that companies in three European and adjacent countries learned of such via the publication. Either adjacent countries crawl Sweden and/or Croatia's publications or one of those countries published in the European publication.
After learning of the patents,companies begin a dd process of the tech and NNLX- which sometimes could more accurately be called corporate espionage in todays dysfunctional world. Including creating or hacking into some government agencies illegal without warrant dossier's.
Then a decision making process begins,followed by communication internally by typically 3 different groups previously specified. Once decision of interest and or to acquire the tech and approval (a multilayered internal process) is made by the potential buyer,at some point they will communicate w NNLX,as companies in at least 3 countries did by 11-27-17.
Since 11-27-17 we can assume other countries published,thus waking up other potential buyers, and discussions with some of the initial implied at least 3 companies (could be multiple companies in any given country) are progressing or not depending on the company.
So a lot of activity is likely continuing. At some stage of interest potential buyers may demand an NDA to keep their interests/plans secret from competitors.
Update on Patents Offered for Sale, UTI Presentation at CAOG, and NSF Grant Application-see post 4050 11-27-17
International Patent Offering
NanoLogix is pleased to provide this update on the ongoing work on the sale of the European and China issued FlatPack patents, the poster presentation dealing with the seriousness of the threat from Urinary Tract Infections (UTI) with the need for new rapid methods for diagnostics for UTI infections, and an in-process application to the National Science Foundation for a $1.5 million grant.
Since our first announcement of the offer of 12 July we have registered the patent in fourteen EU Patent Agreement signatory countries. That registration was completed by 7 September. At that time the official status of the FlatPack patent in Europe was recognized in those fourteen countries. Since 7 September, two of those countries, Sweden and Croatia, out of the fourteen countries in which the patent has been registered, have published that information in either their own national patent bulletins or the EU Patent bulletin. This publication step is generally required in order for a formal acceptance of the patent validity by interested parties. NanoLogix has no control over the timing of individual Country publication and hopes the remainder of the bulletin notifications could be completed by the end of the current quarter, fully realizing each country involved possesses its own separate bureaucracy and timetables. That stated, we are pleased to have had interest in the technology from companies in three European and adjacent countries.
For the offering of the FlatPack patent in China we are using the services of a broker in Asia and have as yet to receive notice of significant interest. China and Intellectual property rights have an interesting and varied history so we hope to find a large entity in China with the vision to recognize, acquire, and protect the granted China patent rights.
Since bashers on message boards state or imply all is lost before the real world PROCESS even has time to play out.
Potential buyers will have patent agents who "crawl" through either new patent applications or newly issued patents, or in the case of the European Union, the country publication of such. Each potential buyer will determine its own timing for crawling through these records (e.g., the patent itself or the publication).
Prior to the internet (yes, for young peoples benefit the world existed before the internet and before computers,calculators, phones and cars etc) you had to physically go to individual offices to pour through the stacks. I personally did this while I was young on a board and then as President (because its almost impossible to find people who know how to or are willing to do things or who can think- a commodity not valued outside of think tanks); long before Al Gore invented the internet,starting about the time dos PC's (brazenly called PC's -just glorified calculators) were invented long before the internet- but in a non-biotech field.
"Since our first announcement of the offer of 12 July we have registered the patent in fourteen EU Patent Agreement signatory countries. That registration was completed by 7 September. At that time the official status of the FlatPack patent in Europe was recognized in those fourteen countries."
Led by the misinformation of bashers some assume nothing is being done between updates. Think about that. Without considerable interim work these substantial updates could not be issued. As president of a corporation I did an incredible amount of work moving things forward in between board meetings,which I led.
So from July 12 to September 7 "we have registered the patent in fourteen EU Patent Agreement signatory countries".
NNLX previous patent attorney took some steps re patents in European countries-you would have to read that previous info to see what.
Big pharma's crawlers will in most cases no doubt crawl at this stage rather than waiting for publication. Lesser pharma and hospital supply organizations more likely would wait until publication.
"Since 7 September, two of those countries, Sweden and Croatia, out of the fourteen countries in which the patent has been registered, have published that information in either their own national patent bulletins or the EU Patent bulletin. This publication step is generally required in order for a formal acceptance of the patent validity by interested parties. NanoLogix has no control over the timing of individual Country publication and hopes the remainder of the bulletin notifications could be completed by the end of the current quarter, fully realizing each country involved possesses its own separate bureaucracy and timetables. That stated, we are pleased to have had interest in the technology from companies in three European and adjacent countries."
So from Sept 7 to 11-27-17 Sweden and Croatia published and the contextual inference is that companies in three European and adjacent countries learned of such via the publication. Either adjacent countries crawl Sweden and/or Croatia's publications or one of those countries published in the European publication.
After learning of the patents,companies begin a dd process of the tech and NNLX- which sometimes could more accurately be called corporate espionage in todays dysfunctional world. Including creating or hacking into some government agencies illegal without warrant dossier's.
Then a decision making process begins,followed by communication internally by typically 3 different groups previously specified. Once decision of interest and or to acquire the tech and approval (a multilayered internal process) is made by the potential buyer,at some point they will communicate w NNLX,as companies in at least 3 countries did by 11-27-17.
Since 11-27-17 we can assume other countries published,thus waking up other potential buyers, and discussions with some of the initial implied at least 3 companies (could be multiple companies in any given country) are progressing or not depending on the company.
So a lot of activity is likely continuing. At some stage of interest potential buyers may demand an NDA to keep their interests/plans secret from competitors.
Update on Patents Offered for Sale, UTI Presentation at CAOG, and NSF Grant Application-see post 4050 11-27-17
International Patent Offering
NanoLogix is pleased to provide this update on the ongoing work on the sale of the European and China issued FlatPack patents, the poster presentation dealing with the seriousness of the threat from Urinary Tract Infections (UTI) with the need for new rapid methods for diagnostics for UTI infections, and an in-process application to the National Science Foundation for a $1.5 million grant.
Since our first announcement of the offer of 12 July we have registered the patent in fourteen EU Patent Agreement signatory countries. That registration was completed by 7 September. At that time the official status of the FlatPack patent in Europe was recognized in those fourteen countries. Since 7 September, two of those countries, Sweden and Croatia, out of the fourteen countries in which the patent has been registered, have published that information in either their own national patent bulletins or the EU Patent bulletin. This publication step is generally required in order for a formal acceptance of the patent validity by interested parties. NanoLogix has no control over the timing of individual Country publication and hopes the remainder of the bulletin notifications could be completed by the end of the current quarter, fully realizing each country involved possesses its own separate bureaucracy and timetables. That stated, we are pleased to have had interest in the technology from companies in three European and adjacent countries.
For the offering of the FlatPack patent in China we are using the services of a broker in Asia and have as yet to receive notice of significant interest. China and Intellectual property rights have an interesting and varied history so we hope to find a large entity in China with the vision to recognize, acquire, and protect the granted China patent rights.
3
